首页> 外文期刊>Clinical oncology >Advances in the Pathology and Molecular Biology of Sarcomas and the Impact on Treatment
【24h】

Advances in the Pathology and Molecular Biology of Sarcomas and the Impact on Treatment

机译:肉瘤病理与分子生物学的进展及对治疗的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Sarcomas are a complex group of childhood and adult neoplasms with differentiation towards mesenchymal tissues that can occur at almost every anatomic site. Although pathologically diverse, they frequently show similar clinical presentations and radiological findings, such that correct histopathologic diagnosis, utilising the appropriate ancillary immunohistochemical and molecular techniques, underpins their management. This article gives an overview of the pathology, coupled with recent advances in molecular biology, of a selection of soft tissue sarcomas from a clinicopathological perspective, discussing histopathological diagnosis with developments in molecular diagnosis and the incorporation of these findings into diagnostic practice and current and potential targeted treatments. (C) 2017 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
机译:肉瘤是一组复杂的儿童和成人肿瘤,朝着在几乎每一个解剖部位发生的间充质组织的分化。 虽然病理差异化,但它们经常显示出类似的临床介绍和放射性发现,使得正确的组织病理学诊断,利用适当的辅助免疫组织化学和分子技术,支撑他们的管理。 本文概述了与分子生物学的最近进步相结合的病理学,从临床病理学的角度选择软组织肉瘤,讨论了分子诊断的发展组织病理学诊断,并将这些发现纳入诊断实践和当前和潜力 有针对性的治疗方法。 (c)2017年皇家放射科医生。 elsevier有限公司出版。保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号